Annual report [Section 13 and 15(d), not S-K Item 405]

Equity

v3.25.1
Equity - USD ($)
1 Months Ended 12 Months Ended
Oct. 15, 2024
Jun. 05, 2024
Jun. 12, 2023
May 31, 2024
Oct. 26, 2023
Dec. 31, 2024
Dec. 31, 2023
Jan. 01, 2024
Share-Based Compensation Expense Allocated to Research and Development           $ 20,000 $ 900,000  
Share-Based Compensation Expense Allocated to General and Administrative           10,275,914 5,897,594  
Total Compensation and Benefits Expense           9,473,513 867,359  
Proceed from stock issuances           5,602,269 485,000  
Director Compensation Expense - Equity           $ 1,511,086 $ 89,502  
Expected Dividends           0.00% 0.00%  
Discount on Stock Issuance $ 26,863              
Closing market price per share $ 21.50         $ 21.50    
Total intrinsic value of all the Company's outstanding options $ 14,000,000.0         $ 2,900,000    
Weighted Average Recognition Period           3 months 18 days    
Unrecognized compensation expense           $ 133,257    
Common stock and treasury shares, Description         1-for-6 basis and (ii) decrease the number of total authorized shares of common stock of the Company from 150,000,000 to 25,000,000 shares      
Common stock shares issuance           793,489 437,692  
Reverse stock split of common stock         As of the Effective Time, every 6 shares of issued and outstanding common stock were converted into one share of common stock      
Agents fee           $ 337,682    
Common stock, par value           $ 0.001 $ 0.001  
Remining shares available for issuance           789,324    
Volatility range           122.46% 112.28%  
Common stock value           $ 3,621 $ 2,383  
Private Investors [Member]                
Common stock shares issuance             563,016  
Restricted Stock [Member]                
Weighted Average Recognition Period           2 months 12 days    
Unrecognized compensation expense           $ 31,135    
Fair market value of RSAs vested           2,507,934    
Restricted Stock [Member] | Director Stock Option Replacement Program [Member]                
Restricted stock were granted under the director equity plan   127,364            
Recognized expense stock option replacement program   $ 671,998            
Outstanding number of option   62,451            
Awarded number of restricted stock issue values       $ 299,996        
Awarded number of restricted stock       37,688        
Awarded number of restricted stock per share       $ 7.96        
Restricted Stock [Member] | Stoc Award Lieuof Unpaid Directors Fees [Member]                
Accounts payable to related party       $ 172,670        
Restricted stock were granted under the director equity plan       261,619        
Recognized expense stock option replacement program       $ 2,077,523        
Awarded number of restricted stock per share       $ 7.96        
Non-employee board members fee       $ 172,670        
Description related to unpaid director fees       unpaid amounts were grossed up for taxes at an assumed tax rate of 45% and the number of shares was determined based on the Company’s closing stock price on December 29, 2023, of $1.20 per share        
Fair Value Measurement, Discount       $ 21,121        
On July 5, 2023                
Proceed from stock issuances           $ 171,666    
Purchase price           $ 16.02    
Agents fee           $ 365,000    
Common stock, par value           $ 0.001    
Exercise price           $ 0.0006    
Pre-funded warrants           78,021    
Gross proceeds of stock           $ 4,000,000    
Offering price           $ 16.0194    
Common stock share issued, restricted           78,021    
Board Of Directors [Member]                
Expenses for options and warrants granted to employees58           $ 9,473,513    
Epenses for R & D obligation           2,222,806    
Expenses was attributed to G & A           7,250,707    
Share-Based Compensation Expense Allocated to Research and Development           232,920    
Share-Based Compensation Expense Allocated to General and Administrative           634,439    
Total Compensation and Benefits Expense           $ 867,359    
Restricted Stock Awards Granted           445,490    
Equity Incentive Plan for Non-Employee Directors           $ 3,258,311    
Unrelated Private Investors [Member]                
Common share sold           598,054    
Common share sold amount           $ 4,283,387    
Related Party [Member]                
Accounts payable to related party           78,101    
Cash           $ 1,240,781    
Common stock shares issuance           195,435    
Proceed from related party           $ 1,318,882    
Black Scholes Pricing Model [Member]                
Grants shares     10,878          
Grants shares, amount     $ 3,626          
Expected Dividends     0.00%          
Proceed from related party     $ 50,000          
Average weighted remaining contructual life in years     5 years 3 months 21 days          
Discount rates     3.88%          
Volatility range     112.25%          
Common stock value     $ 50,000          
Employee Stock Option Replacement Program [Member]                
Outstanding number of option   230,064            
Expected Term   5 years 1 month 6 days            
Expected Dividends   0.00%            
Risk Free Rate   4.29%            
Common stock option shares approved   981,174            
Compensation expense award grant   5,849,520            
Expected Volatility   122.46%            
Securities Purchase Agreement [Member]                
Common stock shares issuance             78,021  
Received from common stock shares issued             $ 47  
Equity Incentive Plan [Member]                
Proceed from stock issuances       $ 875,000        
Incentive plan, description       by the Company to such non-employee director, will not exceed $750,000 in total value or, in the event such non-employee director is first appointed or elected to the Board during such calendar year, $1,000,000 in total value        
Shares remain available to be issued       429,510        
Equity Incentive Plan [Member] | Common Stock Options Member                
Director Compensation Expense - Equity           $ 6,215,202 867,359  
Awarded number of restricted stock           1,031,425    
Twenty Twenty One Incentive Plan [Member]                
Stock options, issued           1,000,000   1,000,000
Twenty Twenty One Incentive Plan [Member] | June 5 2024 [Member]                
Stock options, issued   292,515       1,031,425    
Shares remain available to be issued           261,090    
2021 [Member] | Black Scholes Pricing Model [Member]                
Average weighted remaining contructual life in years           10 years    
Board Annual Service [Member]                
Restricted Stock Awards Granted           18,819    
Equity Incentive Plan for Non-Employee Directors           $ 50,000    
Fair Value of Restricted Stock Awards           $ 187,673    
Restricted Stock Awards Granted and Vested           426,671    
Director Compensation Expense - Equity           $ 3,070,638    
C E O Twenty Twenty Three Equity Award [Member] | Common Stock Options Member                
Awarded number of restricted stock   50,251            
Due amount for exchange of stock option   $ 400,000            
Awarded number of restricted stock per share   $ 7.96            
Compensation expense   $ 338,819            
Expected Term   5 years 1 month 6 days            
Expected Volatility   122.46%            
Expected Dividends   0.00%            
Risk Free Rate   4.29%            
Private Placement Securities [Member]                
Shares available for issuance, shares           249,688    
Exercise price           $ 16.80    
Offering price           $ 16.80    
Common stock share issued, restricted           249,688    
Investor Private Placement Member                
Proceed from stock issuances             $ 640,000  
Stock Warrants Issued [Member]                
Restricted Stock Awards Granted           78,021    
Warrants issued to related parties           6,185    
Warrants issued to purchase common stock           30,924    
Common Stock Warrants Issued           642,397    
Warrants issued to related party           65,000    
Private placement warrants issued           499,376